Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch

Go back to Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch
(NASDAQ: ELUT) Delayed: 0.93 --0 (-0%)
Previous Close $0.93    52 Week High
Open $0.90    52 Week Low
Day High $0.96    P/E N/A 
Day Low $0.90    EPS
Volume 48,288